Results 131 to 140 of about 23,301 (197)

Dissecting minimal residual disease dynamics to improve outcome prediction in mantle cell lymphoma: Data from the Fondazione Italiana Linfomi (FIL)-MCL0208 clinical trial. [PDF]

Hemasphere
Cordero F, Ferrero S, Pernice S, Genuardi E, Volpatto D, Sirovich R, Civita AM, Evangelista A, Ragaini S, Di Rocco A, Re A, Stefoni V, Cavallo F, Boccomini C, Balzarotti M, Zilioli VR, Gomes da Silva M, Arcaini L, Celli M, Zaccaria GM, Tortarolo D, Beccuti M, Hoster E, Pott C, Macintyre E, Hermine O, Dreyling M, Ladetto M.   +27 more
europepmc   +1 more source

Advancing the Diagnosis of Non-Hodgkin Lymphoma Through Next-Generation Sequencing in Developing Countries: An Evaluation of Progress-A Narrative Review. [PDF]

Health Sci Rep
Saeidnia M, Shokri M, Nourmohammadi H, Radmehr S, Babashahi M, Moradi M, Karimian M, Panji M, Motevaseli E.   +8 more
europepmc   +1 more source

Clinical characteristics and prognostic features of patients with blastoid and pleomorphic variant mantle cell lymphoma: a real-world study in China. [PDF]

Ann Hematol
Huang Y, Zhang X, Lv Y, Wei J, Ye X, Zhang X, Yang C, Zhu Y, Wang J, Xu G, Yang M, Meng H, Xie W, Jin J, Tong H, Yu W.   +15 more
europepmc   +1 more source

Minimally required essential bio markers for lymphoma. [PDF]

Bioinformation
Ghanghoria S, Ghanghoria A, Sai Chownika GP, Thakur A, Verma TP, Parmar S.   +5 more
europepmc   +1 more source

Concurrent HHV-8-Associated Multicentric Castleman Disease and Kaposi Sarcoma in an HIV-Negative Patient: A Case Report. [PDF]

Diagnostics (Basel)
Vasile AM, Closca RM, Rakitovan M, Iordache M, Zara F.   +4 more
europepmc   +1 more source

Correction: The HSP90-MYC-CDK9 network drives therapeutic resistance in mantle cell lymphoma. [PDF]

Exp Hematol Oncol
Yan F, Jiang V, Jordan A, Che Y, Liu Y, Cai Q, Xue Y, Li Y, McIntosh J, Chen Z, Vargas J, Nie L, Yao Y, Lee HH, Wang W, Bigcal JR, Badillo M, Meena J, Flowers C, Zhou J, Zhao Z, Simon LM, Wang M.   +22 more
europepmc   +1 more source

A Phase Ib Trial of Copanlisib in Combination with Venetoclax in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma-SAKK 66/18 Trial. [PDF]

Cancers (Basel)
Pirosa MC, Hess D, Krasniqi F, Novak U, Mach N, Zenz T, Holer L, Cascione L, Cannas E, Rinaldi A, Schär S, Zucca E, Bertoni F, Stathis A, Swiss Group for Clinical Cancer Research SAKK.   +14 more
europepmc   +1 more source

Epidemiology, treatment patterns, and survival outcomes of patients with mantle cell lymphoma in Germany: a retrospective analysis of administrative claims data. [PDF]

Ann Hematol
Friedel H, Hennies N, Zschocke J, Hosseini SK, Bölz S, Bocuk D, Wilhelm S, Zaba O, Buske C.   +8 more
europepmc   +1 more source

Appendiceal Intussusception Secondary to Mantle Cell Lymphoma: A Report of a Rare Case. [PDF]

Cureus
Miyata N, Asomah F.
europepmc   +1 more source

Mantle Cell Lymphoma with Persistent Massive Pleural Effusions Requiring Invasive Mechanical Ventilation and Bilateral Continuous Thoracic Drainage. [PDF]

Reports (MDPI)
Tokura T, Imai Y, Sakai S, Saga R, Hidai H, Motomura S.   +5 more
europepmc   +1 more source